Fig. 4From: Microbiome recovery in adult females with uncomplicated urinary tract infections in a randomised phase 2A trial of the novel antibiotic gepotidacin (GSK2140944)Overall trends in changes for specific pathogenic genera including Bacillus, Clostridioides, Escherichia-Shigella, Haemophilus, Neisseria, Staphylococcus and Streptococcus. (* P value ≤0.05; ** P value ≤0.005; *** P value ≤0.0001 ns = nonsignificant)Back to article page